)
Monte Rosa Therapeutic (GLUE) investor relations material
Monte Rosa Therapeutic TD Cowen Immunology and Inflammation Summit summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and strategy
Focuses on molecular glue degraders to target previously undruggable proteins in inflammation, immunity, and oncology.
Operates from Boston and Basel, with three clinical programs: Vav1 degrader (MRT-6160), NEK7 degrader (MRT-8102), and GSPT-1 degrader (MRT-2359).
Vav1 degrader licensed to Novartis and advancing to phase two; NEK7 and GSPT-1 programs are in clinical trials.
NEK7 degrader (MRT-8102) program
NEK7 is essential for NLRP3 inflammasome assembly; degrading NEK7 prevents inflammasome formation, differentiating it from NLRP3 inhibitors.
Preclinical and GLP toxicology studies in animals showed no significant safety concerns at high doses.
Proteomic data indicate high selectivity for NEK7, with no off-target degradation among NEK family proteins.
Degradation leads to sustained inhibition, as NEK7 levels take days to recover post-treatment.
Phase one includes healthy volunteers and patients with cardiovascular risk; data readout expected in the first half of next year.
Biomarkers and clinical endpoints
CRP is a key pharmacodynamic marker, with established benchmarks from prior IL-1/NLRP3 studies.
Cytokines like IL-1β, IL-18, and IL-6 are also tracked, though require ex vivo stimulation in healthy subjects.
Phase one design incorporates standard single and multiple ascending dose parts, plus a patient cohort with elevated CRP.
Next Monte Rosa Therapeutic earnings date
Next Monte Rosa Therapeutic earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)